| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 06/06/1995 | US5422426 Solid phase synthesis of oligopeptides for testing as ligands for enzymes and cellular receptors; controlling the concentration and ratios |
| 06/06/1995 | US5422284 Method of performing affinity separation using immobilized flocculating agent on chromatographic support |
| 06/06/1995 | US5422279 Lipid fractionation |
| 06/06/1995 | US5422249 Process for the manufacture of thrombin inhibitors |
| 06/06/1995 | US5422103 Wound healing agents for burns, bed sores; blended with dextran |
| 06/06/1995 | US5421980 Filling an internally coated capillary with a gel which is already polymerized, coating prevents bonding of gel and wall; used for separating biological samples into its molecular species |
| 06/06/1995 | CA1335805C Isoelectric focusing process and a means for carrying out said process |
| 06/06/1995 | CA1335802C O-glycosylated igf-1 |
| 06/06/1995 | CA1335765C Whey protein fractions |
| 06/01/1995 | WO1995014929A1 Dimeric oligopeptide mixture sets |
| 06/01/1995 | WO1995014710A1 Chemically modified binding protein |
| 05/31/1995 | EP0655462A1 Linear adhesion inhibitors |
| 05/31/1995 | EP0655135A1 Random generation and bio-specific selection of chemical compounds |
| 05/31/1995 | EP0655069A1 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems |
| 05/31/1995 | EP0557270B1 Cationized antibodies for delivery through the blood-brain barrier |
| 05/31/1995 | EP0553281B1 Preparation and characterization of liposomal formulations of tumor necrosis factor |
| 05/31/1995 | EP0401369B1 Method for preparative expression of genes in a cell-free system of conjugated transcription/translation |
| 05/31/1995 | CN1103068A Amino-acid low peptide preparing method |
| 05/30/1995 | US5420805 Method and apparatus for designing molecular structures using an analytical solution for effective born radii |
| 05/30/1995 | US5420338 Method for the production of α-L-aspartyl-L-phenylalanine methyl ester hydrochloride |
| 05/30/1995 | US5420297 Peptides having substance P antagonistic activity |
| 05/30/1995 | US5420252 For treatment of thrombotic disorders |
| 05/30/1995 | US5420249 Incubation of proteins and separation |
| 05/30/1995 | US5420248 Acid soluble proteins |
| 05/30/1995 | US5420246 Having a predetermined amount of each peptide |
| 05/30/1995 | US5419899 Purified, reduced recombinant interleukin-2 compositions |
| 05/30/1995 | US5419874 Synthesis reaction column |
| 05/30/1995 | CA1335722C Polyethylene glycol derivatives, modified peptides and production thereof |
| 05/30/1995 | CA1335719C Efficient process for producing active chymosin from a precursor protein synthesized in bacteria |
| 05/30/1995 | CA1335717C Human granulocyte-macrophage colony stimulating factor and muteins thereof |
| 05/26/1995 | WO1995014118A1 Methods for the separation of biological materials |
| 05/26/1995 | WO1995014110A1 Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease |
| 05/26/1995 | WO1995014038A2 Purification of hemoglobin |
| 05/26/1995 | WO1995014035A1 Method for purification of a mixture of hydroxamate derivatized protein and native protein |
| 05/26/1995 | WO1995014034A1 Use of igf-bp for refolding of igf |
| 05/26/1995 | WO1995013795A1 Hydrophobic preparations |
| 05/26/1995 | CA2176599A1 Use of igf-bp for refolding of igf |
| 05/26/1995 | CA2176577A1 Hydrophobic preparations |
| 05/26/1995 | CA2175591A1 Method for purification of a mixture of hydroxamate derivatized protein and native protein |
| 05/26/1995 | CA2175374A1 Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease |
| 05/24/1995 | EP0654481A1 Process for producing alpha-L-aspartyl-L-phenylalanine methyl ester |
| 05/24/1995 | EP0654480A1 Process for producing alpha-L-aspartyl-L-pheylalanine methyl ester |
| 05/24/1995 | EP0654307A1 Method of two-dimensional aggregation and fixation of protein |
| 05/24/1995 | EP0654061A1 A method of chemical coupling on solid phases |
| 05/24/1995 | EP0654040A1 Pharmaceutical composition containing botulinum b complex |
| 05/24/1995 | EP0653965A1 Fluid delivery system uitlizing multiple port valve. |
| 05/24/1995 | EP0574394B1 Substances of polypeptide nature useful in human therapy |
| 05/24/1995 | EP0573599B1 Crystallizing biological macromolecules in microgravity |
| 05/24/1995 | EP0549706B1 Cationic charge modified microporous membranes |
| 05/23/1995 | US5418135 Method of inhibiting binding of PDGF to a PDGF receptor by biosynthetic PDGF antagonists |
| 05/23/1995 | CA1335666C Extraction and purification of an anticoagulant principle from the south american leech, haementeria ghilianii |
| 05/23/1995 | CA1335662C Peptide derivatives for the treatment and prevention of asthma and the like |
| 05/18/1995 | WO1995013538A1 Methods of producing and screening complex chemical libraries |
| 05/18/1995 | WO1995013302A1 Cathepsin-l-specific inhibitor polypeptide |
| 05/18/1995 | WO1995013293A1 Fas LIGAND, PART THEREOF, AND DNA CODING FOR THE SAME |
| 05/18/1995 | WO1995013288A1 Surface membrane proteins and their effect on immune response |
| 05/18/1995 | WO1995013090A1 Improved interferon polymer conjugates |
| 05/18/1995 | CA2176208A1 Surface membrane proteins and their effect on immune response |
| 05/18/1995 | CA2151059A1 Cathepsin-l-specific inhibitor polypeptide |
| 05/17/1995 | EP0652900A1 Thrombin inhibitors |
| 05/17/1995 | EP0652891A1 T-cell membrane inducing factors |
| 05/17/1995 | EP0652886A1 Esterification process |
| 05/17/1995 | EP0652798A1 Sorbent families |
| 05/16/1995 | US5416202 Such as gelonin, cysteine substitution |
| 05/16/1995 | US5416194 Extracted from horseshoe crab |
| 05/16/1995 | US5416193 Polymer with carbodiimide pendant groups |
| 05/16/1995 | US5415995 Diagnostic peptides of human papilloma virus |
| 05/16/1995 | US5415859 Production and use of antheimintic agents and protective antigens |
| 05/11/1995 | WO1995012808A1 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| 05/11/1995 | WO1995012672A1 Manufacture and use of polypeptides tagged using binding molecules |
| 05/11/1995 | WO1995012609A1 Process for producing a virus-inactivated factor viii-containing fraction by chromatographic methods |
| 05/11/1995 | WO1995012608A1 Synthesizing and screening molecular diversity |
| 05/11/1995 | CA2175587A1 Synthesizing and screening molecular diversity |
| 05/11/1995 | CA2175209A1 Manufacture and use of polypeptides tagged using binding molecules |
| 05/10/1995 | EP0652231A1 NON-TOXIC RIBOSOME INACTIVATING PROTEINS (RIPs) WITH TWO CHAINS, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS |
| 05/10/1995 | EP0651883A1 Peptides useful as internal standards for microsequencing and methods for their use |
| 05/10/1995 | EP0651820A1 MONOCLONAL ANTIBODIES AGAINST THE $g(a)-TNF TYPE I RECEPTOR, PROCESS FOR THE PRODUCTION AND USE THEREOF |
| 05/10/1995 | EP0651799A1 Fibrin binding domain polypeptides and uses and methods of producing same |
| 05/10/1995 | EP0651765A1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 05/10/1995 | EP0651762A1 Method and apparatus for the rapid synthesis of substrate-bound or free peptides or oligonucleotides, flat material synthesized in this way and the use of such material |
| 05/10/1995 | EP0651761A1 Method for modification of recombinant polypeptides |
| 05/10/1995 | EP0301078B1 Polypeptides with activity against gram-positive and gram-negative bacteria |
| 05/09/1995 | US5414135 Vinyl sulfone coupling of polyoxyalkylenes to proteins |
| 05/09/1995 | US5414089 Useful for modifying enzymes or proteins |
| 05/09/1995 | US5414085 Barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels |
| 05/09/1995 | US5413910 Measuring non-dystrophin proteins and diagnosing muscular dystrophy |
| 05/09/1995 | US5413774 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
| 05/09/1995 | CA1335493C Process for the preparation of tripeptides |
| 05/04/1995 | WO1995011998A1 Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics |
| 05/04/1995 | WO1995011987A1 Chimeric proteins including protease nexin-1 variants |
| 05/04/1995 | WO1995011966A1 Human activated protein c preparation and process for producing the same |
| 05/04/1995 | WO1995011917A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
| 05/04/1995 | WO1995011916A1 A method for identifying anti-parasitic compounds |
| 05/04/1995 | WO1995011912A2 Biopolymer synthesis utilizing surface activated, organic polymers |
| 05/04/1995 | WO1995011748A1 Method and apparatus for creating biopolymer arrays on a solid support surface |
| 05/04/1995 | CA2175579A1 Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics |
| 05/04/1995 | CA2173590A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
| 05/03/1995 | EP0650975A1 Refolding of denatured proteins using chaperonin 60 monomers from Thermus thermophilus |
| 05/03/1995 | EP0650497A1 A process for recovering a recombinant protein, in biologically active form, from a solution containing inactive protein |
| 05/03/1995 | EP0650478A1 Method of forming n-protected amino acid thiohydantoins |